finasteride has been researched along with Aging in 23 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (21.74) | 18.2507 |
2000's | 8 (34.78) | 29.6817 |
2010's | 10 (43.48) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bjorling, DE; Macoska, J; Marker, PC; Mueller, B; Peterson, RE; Ricke, WA; Ruetten, H; Sandhu, J; Sandhu, S; Vezina, CM; Wang, P; Wang, Z; Wegner, KA; Zhang, HL | 1 |
Ogaeri, T; Samsonov, M; Sokabe, M; Tanaka, M | 1 |
Culig, Z; Madersbacher, S; Sampson, N | 1 |
Antoshina, EE; Belitsky, GA; Blagosklonny, MV; Chernova, OB; Gorkova, TG; Kirsanov, KI; Lesovaya, EA; Salimov, RM; Shipaeva, EV; Trukhanova, LS; Yakubovskaya, MG | 1 |
Cagnon, VH; Kido, LA; Montico, F; Rowley, DR; San Martin, R | 1 |
Goodier, M; Hordinsky, M | 1 |
Dabanović, V; Janković, S; Kostić, M | 1 |
Buksman, S; Carmo, AM; Clapauch, R; Marinheiro, L; Pessoa, I | 1 |
Campos, SG; Corradi, LS; Góes, RM; Santos, FC; Taboga, SR; Vilamaior, PS | 1 |
Alcaraz, A; Castro, R; Desgrandchamps, F; Hammerer, P; Montorsi, F; Schröder, F | 1 |
Darbra, S; Pallarès, M | 1 |
Buckley, KE; Sengelaub, DR; Sergent, MA; Verhovshek, T | 1 |
Chen, LF; Du, XL; Ma, HS; Ma, YX; Shi, JD; Yang, R; Yang, ZP; Zhang, J; Zhou, Y; Zhu, Y | 1 |
Amory, JK; Anawalt, BD; Bowman, FD; Bremner, WJ; Matsumoto, AM; Page, ST; Tenover, JL | 1 |
Crawford, ED; Kaplan, SA | 1 |
Steers, WD; Zorn, B | 1 |
Krieg, M; Tunn, S; Weisser, H | 1 |
DuBeau, CE | 1 |
Hata, S; Ishii, Y; Mukoyama, H | 1 |
Jung, K; Lein, M; Loening, SA; Meyer, A; Rudolph, B; Schnorr, D | 1 |
Bartsch, G; Klocker, H; Rittmaster, RS | 2 |
Dhooge, WS; Eechaute, WP; Gao, CQ; Kaufman, JM; Weyne, JJ | 1 |
6 review(s) available for finasteride and Aging
Article | Year |
---|---|
Pathophysiology of Benign Prostatic Hyperplasia and Benign Prostatic Enlargement: A Mini-Review.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Aging; Diabetes Mellitus; Dihydrotestosterone; Dutasteride; Dyslipidemias; Finasteride; Humans; Inflammation; Lower Urinary Tract Symptoms; Male; Metabolic Syndrome; Prostatic Hyperplasia; Receptors, Androgen | 2019 |
Normal and aging hair biology and structure 'aging and hair'.
Topics: 5-alpha Reductase Inhibitors; Aging; Alopecia; Finasteride; Hair; Hair Follicle; Humans; Melanocytes; Minoxidil; Phototherapy; Scalp; Stem Cells; Telomere Shortening; Vasodilator Agents | 2015 |
A broader role for 5ARIs in prostate disease? Existing evidence and emerging benefits.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Aged; Aging; Azasteroids; Dihydrotestosterone; Dutasteride; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Sulfonamides; Tamsulosin; Testosterone; Urinary Tract Infections | 2009 |
Benign prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Aging; Dihydrotestosterone; Finasteride; Humans; Male; Prostate; Prostatectomy; Prostatic Hyperplasia; Urodynamics | 1995 |
Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Aged; Aging; Clinical Trials as Topic; Dihydrotestosterone; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Prognosis; Prostatic Hyperplasia; Sensitivity and Specificity | 2000 |
Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Administration, Oral; Aged; Aging; Azasteroids; Clinical Trials, Phase III as Topic; Controlled Clinical Trials as Topic; Dihydrotestosterone; Dose-Response Relationship, Drug; Drug Administration Schedule; Dutasteride; Finasteride; Humans; Male; Middle Aged; Multicenter Studies as Topic; Probability; Prognosis; Prostatic Hyperplasia; Treatment Outcome | 2002 |
1 trial(s) available for finasteride and Aging
Article | Year |
---|---|
Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T.
Topics: Adiponectin; Aged; Aged, 80 and over; Aging; Androgens; Body Composition; Body Mass Index; Double-Blind Method; Drug Therapy, Combination; Enzyme Inhibitors; Finasteride; Hand Strength; Humans; Hypogonadism; Insulin; Intercellular Signaling Peptides and Proteins; Leptin; Lipids; Male; Motor Activity; Testosterone | 2005 |
16 other study(ies) available for finasteride and Aging
Article | Year |
---|---|
Impact of sex, androgens, and prostate size on C57BL/6J mouse urinary physiology: functional assessment.
Topics: 5-alpha Reductase Inhibitors; Aging; Androgens; Animals; Epithelial Cells; Female; Finasteride; Male; Mice; Mice, Inbred C57BL; Orchiectomy; Prostate; Sex Characteristics; Testosterone; Urinary Tract Physiological Phenomena; Urodynamics | 2019 |
The 5α-Reductase Inhibitor Finasteride Exerts Neuroprotection Against Ischemic Brain Injury in Aged Male Rats.
Topics: 5-alpha Reductase Inhibitors; Age Factors; Aging; Analysis of Variance; Animals; Brain Injuries; Disease Models, Animal; Dose-Response Relationship, Drug; Finasteride; Infarction, Middle Cerebral Artery; Male; Motor Skills; Neuroprotective Agents; Phosphopyruvate Hydratase; Rats; Rats, Sprague-Dawley; Time Factors | 2019 |
Rapatar, a nanoformulation of rapamycin, decreases chemically-induced benign prostate hyperplasia in rats.
Topics: Aging; Animals; Antibiotics, Antineoplastic; Disease Models, Animal; Drug Administration Schedule; Finasteride; Male; Nanomedicine; Prostate; Prostatic Hyperplasia; Rats; Rats, Wistar; Sirolimus; Sulpiride; Testosterone; TOR Serine-Threonine Kinases | 2015 |
Reactive stroma in the prostate during late life: The role of microvasculature and antiangiogenic therapy influences.
Topics: Age Factors; Aging; Angiogenesis Inhibitors; Animals; Finasteride; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microvessels; Prostate; Prostatic Neoplasms; Stromal Cells | 2015 |
Cost effectiveness comparison of dutasteride and finasteride in patients with benign prostatic hyperplasia--The Markov model based on data from Montenegro.
Topics: 5-alpha Reductase Inhibitors; Aged; Aging; Budgets; Cost-Benefit Analysis; Dutasteride; Finasteride; Humans; Male; Markov Chains; Montenegro; Prostatic Hyperplasia; Quality of Life; Treatment Outcome | 2016 |
Laboratory diagnosis of late-onset male hypogonadism andropause.
Topics: Age Factors; Aged; Aged, 80 and over; Aging; Albumins; Androgens; Andropause; Body Mass Index; Diagnosis, Differential; Enzyme Inhibitors; Finasteride; Humans; Hypogonadism; Male; Middle Aged; Sensitivity and Specificity; Sex Hormone-Binding Globulin; Testosterone | 2008 |
Long-term inhibition of 5-alpha reductase and aromatase changes the cellular and extracellular compartments in gerbil ventral prostate at different postnatal ages.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Aging; Animals; Aromatase; Aromatase Inhibitors; Body Weight; Cell Compartmentation; Enzyme Inhibitors; Estradiol; Finasteride; Gerbillinae; Male; Microscopy, Electron; Organ Size; Prostate; Testosterone | 2009 |
Alterations in neonatal neurosteroids affect exploration during adolescence and prepulse inhibition in adulthood.
Topics: 5-alpha Reductase Inhibitors; Aging; Animals; Animals, Newborn; Anti-Anxiety Agents; Brain; Enzyme Inhibitors; Exploratory Behavior; Female; Finasteride; Male; Midazolam; Neural Inhibition; Neurotransmitter Agents; Pregnanolone; Rats; Rats, Wistar; Reflex, Startle; Sexual Maturation | 2010 |
Testosterone metabolites differentially maintain adult morphology in a sexually dimorphic neuromuscular system.
Topics: Aging; Androgens; Animals; Aromatase Inhibitors; Cholestenone 5 alpha-Reductase; Dendrites; Dihydrotestosterone; Enzyme Inhibitors; Estrogens; Fadrozole; Finasteride; Male; Motor Neurons; Muscle, Skeletal; Orchiectomy; Rats; Sex Characteristics; Testosterone | 2010 |
Antagonism of estrogen-mediated cell proliferation by raloxifene in prevention of ageing-related prostatic hyperplasia.
Topics: 5-alpha Reductase Inhibitors; Aging; Animals; Cell Line; Cell Proliferation; Estrogen Antagonists; Finasteride; Humans; Male; Models, Animal; Proliferating Cell Nuclear Antigen; Prostate; Prostatic Hyperplasia; Raloxifene Hydrochloride; Rats; Rats, Wistar; Selective Estrogen Receptor Modulators; Tamoxifen | 2010 |
Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Aged; Aging; Dihydrotestosterone; Enzyme Inhibitors; Finasteride; Humans; Insulin; Insulin Resistance; Male; Mitochondria; Prostate; Testosterone | 2006 |
Potential activities of androgen metabolizing enzymes in human prostate.
Topics: Adult; Aged; Aging; Androgens; Cholestenone 5 alpha-Reductase; Dihydrotestosterone; Epithelium; Finasteride; Humans; Kinetics; Male; Middle Aged; Oxidoreductases; Prostate; Prostatic Hyperplasia | 1995 |
Finasteride for benign prostatic hyperplasia.
Topics: Aged; Aging; Androstenes; Azasteroids; Finasteride; Humans; Male; Prostatic Hyperplasia; Urodynamics | 1993 |
Metabolism of finasteride in rat hepatic microsomes: age and sex differences and effects of P450 inducers.
Topics: Aging; Animals; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Induction; Female; Finasteride; In Vitro Techniques; Isoenzymes; Male; Microsomes, Liver; Rats; Rats, Sprague-Dawley; Sex Factors | 1994 |
Factors influencing the ratio of free to total prostate-specific antigen in serum.
Topics: Adult; Aged; Aged, 80 and over; Aging; alpha 1-Antichymotrypsin; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Organ Size; Prostate; Prostate-Specific Antigen; Prostatic Diseases; Protein Binding; Reference Values | 1997 |
Hypothalamic 5 alpha-reductase and 3 alpha-oxidoreductase activity in the male rat.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Adrenalectomy; Aging; Animals; Carbon Radioisotopes; Castration; Enzyme Inhibitors; Estrone; Finasteride; Follicle Stimulating Hormone; Hypothalamus; Luteinizing Hormone; Male; Oxidoreductases; Progesterone; Rats; Rats, Wistar; Testosterone | 2002 |